Loading…
IMVARIA is a Berkeley, CA-based software-as-medical-device company that develops AI-driven digital biomarkers to help clinicians diagnose and prognose diseases earlier, with the aim of reducing the need for invasive biopsies. Its platform uses machine learning and deep learning to generate software-only biomarkers from imaging and other data, with demonstrated work on interstitial lung disease and idiopathic pulmonary fibrosis (e.g., ATS 2023 presentations). IMVARIA collaborates with Mayo Clinic on AI-based cancer digital biomarkers, leveraging Mayo’s data assets to develop biomarkers for lung cancer and expand understanding of cancer through large-scale datasets.
AI named IMVARIA from June 2026 to September 2026.
Question: Which startups help doctors use patient-specific diagnostics to choose treatments earlier?
ChatGPT SearchJun 25, 2026
IMVARIA developed Fibresolve, an FDA-authorized AI diagnostic tool for lung fibrosis.
AI cited imvaria.com more than any other site in the answers that named IMVARIA.
imvaria.com 13%Other sites 87%
Excerpts where IMVARIA appeared in the AI's answer
IMVARIA developed Fibresolve, an FDA-authorized AI diagnostic tool for lung fibrosis.
